Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Guardant Health, Inc. (GH)
USD162.42
+4.02 (+2.54%)
US NASDAQ S&P 500
Healthcare Medical - Diagnostics & Research
Address
505 Penobscot Drive 94063
Palo Alto, CA, US
Palo Alto, CA, US
CEO
Helmy Eltoukhy
Website
guardanthealth.com
IPO
2018-10-04
CIK 1576280 ISIN US40131M1099
Description
Guardant Health, Inc., established in Redwood City, California, in 2011, is a precision oncology company that delivers a range of diagnostic blood tests, comprehensive data sets, and advanced analytical solutions both within the United States and internationally. For patients with advanced-stage cancer, the company's core offerings include several liquid biopsy-based tests such as Guardant360 (available in LDT and CDx versions) and GuardantOMNI. Complementing these diagnostic tools, Guardant Health also provides GuardantINFORM, an in-silico research platform leveraging an extensive clinical-genomic liquid biopsy dataset derived from advanced cancer patients. Innovation is a key focus, with the company currently developing the LUNAR-2 test, designed for the early detection of colorectal cancer in eligible asymptomatic individuals. Another emerging solution in development is GuardantConnect, an integrated software platform intended to link biopharmaceutical and clinical clients by connecting patients whose Guardant360 tests reveal actionable alterations with potentially relevant clinical trials. Furthermore, Guardant Health offers the Guardant Reveal Test, which aids in selecting neoadjuvant and adjuvant treatments for early-stage cancer patients. Its portfolio also includes a Guardant360 product for tissue genotyping and Guardant-19 for novel coronavirus detection. The company extends its expertise to biopharmaceutical companies and medical institutions through various development services, encompassing companion diagnostic development, regulatory approval support, clinical study management (including setup, monitoring, and maintenance), testing development, and kit fulfillment.
News Sentiment (7d)
3 articles
- ISCG vs. RZG: Which Small-Cap Growth ETF Is the Better Buy for Investors? Fool - Investing News
- The Surprising Reason Guardant Health, A Top 3% Stock, Soared To A Five-Year High Investors Business Daily
- Guardant Health to Report Second Quarter 2026 Financial Results on July 30, 2026 Business Wire
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Index membership
| Index | Added | Removed | Status |
|---|---|---|---|
| S&P 500 | 1957-03-04 | — | Active |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD162.42
+4.02 (+2.54%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
3M
Beta
1.59
Float Shares
126.09M
Free Float %
96.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.06% | +4.20% | +23.04% | -5.89% | -1.15% | -5.32% | +132.14% | +266.74% | -15.11% | +200.34% | +200.34% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (30 ratings, all time)
Buy
Price Targets & DCF
Current price
162.42
Low
110.00
-32.3%
Consensus
133.14
-18.0%
Median
130.00
-20.0%
High
175.00
+7.7%
Ratings Trend (MoM)
91% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | -1 |
| Buy | 16 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
115.00
-29.2%
|
| Last Quarter | 9 |
127.11
-21.7%
|
| Last Year | 35 |
112.49
-30.7%
|
| All Time | 54 |
93.69
-42.3%
|
Quality scores
Altman Z-Score
1.90
Grey zone
Piotroski F-Score
4 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Diagnostics & Research: +7.9%+32.9% ★ Q1'26: +48.3% (vs Q1'25)
-
EPS growth Medical - Diagnostics & Research: +30.8%+6.7% Q1'26: -10.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%-41.4% Q1'26: -23.6% (vs Q1'25)
-
EBIT margin Medical - Diagnostics & Research: +9.6%-42.1% Q1'26: -36.6% (vs Q1'25)
-
ROIC Medical - Diagnostics & Research: +5.2%-108.4% Q1'26: -112.4% (vs Q1'25)
-
Share dilution Medical - Diagnostics & Research: 0.0%+2.1% Q1'26: +6.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×-4.50× Q1'26: -4.15× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 15 Rev. Ana. 10 EPS Ana. |
Dec 2027 16 Rev. Ana. 9 EPS Ana. |
Dec 2028 12 Rev. Ana. 7 EPS Ana. |
Dec 2029 11 Rev. Ana. 2 EPS Ana. |
Dec 2030 6 Rev. Ana. 5 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
90.64M
est: 83.33M (+8.8%)
|
214.38M
est: 206.24M (+3.9%)
|
286.73M
est: 284.99M (+0.6%)
|
373.65M
est: 364.29M (+2.6%)
|
449.54M
est: 446.54M (+0.7%)
|
563.95M
est: 643.81M (-12.4%)
|
739.02M
est: 729.04M (+1.4%)
|
982.02M
est: 973.05M (+0.9%)
|
1.29B
1.28B – 1.30B
+32.9% YoY
|
1.66B
1.63B – 1.75B
+28.4% YoY
|
2.10B
2.08B – 2.11B
+26.2% YoY
|
2.62B
2.54B – 2.74B
+24.9% YoY
|
3.07B
2.99B – 3.21B
+17.5% YoY
|
| EBITDA |
-75.84M
est: -67.39M (-12.5%)
|
-54.93M
est: -78.87M (+30.4%)
|
-225.07M
est: -202.85M (-11.0%)
|
-359.62M
est: -348.77M (-3.1%)
|
-614.91M
est: -476.24M (-29.1%)
|
-433.31M
est: -468.62M (+7.5%)
|
-390.12M
est: -530.66M (+26.5%)
|
-373.91M
est: -708.27M (+47.2%)
|
-941.58M
-948.99M – -934.16M
-32.9% YoY
|
-1.21B
-1.28B – -1.19B
-28.4% YoY
|
-1.53B
-1.54B – -1.51B
-26.2% YoY
|
-1.91B
-1.99B – -1.85B
-24.9% YoY
|
-2.24B
-2.34B – -2.17B
-17.5% YoY
|
| EBIT |
-82.97M
est: -71.18M (-16.6%)
|
-68.54M
est: -105.48M (+35.0%)
|
-241.14M
est: -224.70M (-7.3%)
|
-381.89M
est: -379.79M (-0.6%)
|
-650.87M
est: -446.90M (-45.6%)
|
-476.19M
est: -495.84M (+4.0%)
|
-432.51M
est: -561.48M (+23.0%)
|
-413.64M
est: -749.41M (+44.8%)
|
-996.27M
-1.00B – -988.43M
-32.9% YoY
|
-1.28B
-1.35B – -1.26B
-28.4% YoY
|
-1.61B
-1.63B – -1.60B
-26.2% YoY
|
-2.02B
-2.11B – -1.96B
-24.9% YoY
|
-2.37B
-2.47B – -2.30B
-17.5% YoY
|
| Net Income |
-85.06M
est: -194.92M (+56.4%)
|
-75.65M
est: -95.22M (+20.6%)
|
-253.78M
est: -221.25M (-14.7%)
|
-405.67M
est: -372.37M (-8.9%)
|
-654.59M
est: -508.23M (-28.8%)
|
-479.45M
est: -517.60M (+7.4%)
|
-436.37M
est: -413.82M (-5.5%)
|
-416.28M
est: -388.85M (-7.1%)
|
-379.86M
-438.26M – -342.24M
+2.3% YoY
|
-261.16M
-353.35M – -116.35M
+31.2% YoY
|
-33.23M
-252.17M – 206.75M
+87.3% YoY
|
164.46M
158.35M – 174.11M
+595.0% YoY
|
331.44M
319.13M – 350.89M
+101.5% YoY
|
| SGA |
89.66M
est: 77.99M (+15.0%)
|
139.73M
est: 182.62M (-23.5%)
|
299.28M
est: 266.53M (+12.3%)
|
398.52M
est: 340.92M (+16.9%)
|
463.78M
est: 415.76M (+11.6%)
|
451.03M
est: 560.70M (-19.6%)
|
545.06M
est: 634.93M (-14.2%)
|
706.07M
est: 847.44M (-16.7%)
|
1.13B
1.12B – 1.14B
+32.9% YoY
|
1.45B
1.42B – 1.53B
+28.4% YoY
|
1.83B
1.81B – 1.84B
+26.2% YoY
|
2.28B
2.21B – 2.38B
+24.9% YoY
|
2.68B
2.60B – 2.80B
+17.5% YoY
|
| EPS |
-1.00
est: -1.59 (+37.0%)
|
-0.75
est: -0.87 (+14.1%)
|
-2.53
est: -2.18 (-16.2%)
|
-3.80
est: -4.26 (+10.8%)
|
-6.41
est: -6.45 (+0.7%)
|
-4.28
est: -4.08 (-4.8%)
|
-3.56
est: -3.41 (-4.3%)
|
-3.32
est: -3.08 (-7.7%)
|
-2.95
-3.50 – -2.73
+4.5% YoY
|
-1.99
-2.82 – -0.93
+32.3% YoY
|
-0.48
-2.01 – 1.65
+75.7% YoY
|
1.31
1.26 – 1.39
+371.2% YoY
|
2.64
2.55 – 2.80
+101.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-79.30M
OE per share TTM
-0.63
Owner's Yield
-0.65%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
47.5%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
137
Total invested
417.08M
Insider transactions (90d)
4
Beneficial owners (>5%)
33
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Abigail P. Johnson | 10.76M | 10.57% | — | — | 10.76M | — | IN | United States of America | 2022-02-10 | ↗ |
| 2 | FMR LLC | 10.76M | 10.57% | 1.80M | — | 10.76M | — | HC | Delaware | 2022-02-10 | ↗ |
| 3 | Wellington Group Holdings LLP | 10.13M | 8.23% | — | 9.99M | — | — | HC | Massachusetts | 2024-11-08 | ↗ |
| 4 | Wellington Investment Advisors Holdings LLP | 10.13M | 8.23% | — | 9.99M | — | — | HC | Massachusetts | 2024-11-08 | ↗ |
| 5 | Wellington Management Group LLP | 10.13M | 8.23% | — | 9.99M | — | — | HC | Massachusetts | 2024-11-08 | ↗ |
| 6 | Wellington Management Company LLP | 10.05M | 8.17% | — | 9.99M | — | — | IA | Massachusetts | 2024-11-08 | ↗ |
| 7 | The Vanguard Group - 23-1945930 | 7.62M | 7.62% | — | 62.4K | — | 126.3K | IA | Pennsylvania | 2021-02-10 | ↗ |
| 8 | Cadian Capital Management GP, LLC | 7.01M | 5.70% | — | 7.01M | — | 7.01M | HC, OO | Delaware | 2024-11-13 | ↗ |
| 9 | Cadian Capital Management, LP | 7.01M | 5.70% | — | 7.01M | — | 7.01M | IA, PN | Delaware | 2024-11-13 | ↗ |
| 10 | Eric Bannasch | 7.01M | 5.70% | — | 7.01M | — | 7.01M | HC, IN | Delaware | 2024-11-13 | ↗ |
| 11 | David Kroin | 6.58M | 5.35% | — | 6.58M | — | — | HC, IN | Delaware | 2024-10-07 | ↗ |
| 12 | Deep Track Biotechnology Master Fund, Ltd. | 6.58M | 5.35% | — | 6.58M | — | — | CO | Delaware | 2024-10-07 | ↗ |
| 13 | Deep Track Capital, LP | 6.58M | 5.35% | — | 6.58M | — | — | IA, OO | Delaware | 2024-10-07 | ↗ |
| 14 | Baillie Gifford & Co (Scottish partnership) | 6.18M | 11.00% | — | — | — | — | IA | SCOTLAND UK | 2024-01-29 | ↗ |
| 15 | (1) BlackRock, Inc. | 5.50M | 5.40% | 5.26M | — | 5.50M | — | HC | Delaware | 2023-02-03 | ↗ |
| 16 | David C. Ott | 5.12M | 5.00% | — | 5.12M | — | 5.12M | IN | Delaware | 2022-01-18 | ↗ |
| 17 | O. Andreas Halvorsen | 5.12M | 5.00% | — | 5.12M | — | 5.12M | IN | Delaware | 2022-01-18 | ↗ |
| 18 | Rose S. Shabet | 5.12M | 5.00% | — | 5.12M | — | 5.12M | IN | Delaware | 2022-01-18 | ↗ |
| 19 | Viking Global Investors LP | 5.12M | 5.00% | — | 5.12M | — | 5.12M | PN | Delaware | 2022-01-18 | ↗ |
| 20 | Morgan Stanley | 4.95M | 4.80% | — | 4.55M | — | 4.95M | HC, CO | Delaware. | 2022-12-09 | ↗ |
| 21 | Morgan Stanley Investment Management Inc. | 4.63M | 4.50% | — | 4.25M | — | 4.63M | IA, CO | Delaware. | 2022-12-09 | ↗ |
| 22 | Helmy A. Eltoukhy | 4.48M | 4.40% | 3.82M | 664.0K | 3.82M | 664.0K | IN | United States of America | 2021-01-07 | ↗ |
| 23 | Viking Global Performance LLC | 3.43M | 3.40% | — | 3.43M | — | 3.43M | OO | Delaware | 2022-01-18 | ↗ |
| 24 | Viking Global Equities Master Ltd. | 3.36M | 3.30% | — | 3.36M | — | 3.36M | CO | Delaware | 2022-01-18 | ↗ |
| 25 | 10 | 2.33M | 2.50% | — | 2.33M | — | 2.33M | PN | CAYMAN ISLANDS | 2020-02-14 | ↗ |
| 26 | Viking Long Fund GP LLC | 1.28M | 1.30% | — | 1.28M | — | 1.28M | OO | Delaware | 2022-01-18 | ↗ |
| 27 | Viking Long Fund Master Ltd. | 1.28M | 1.30% | — | 1.28M | — | 1.28M | CO | Delaware | 2022-01-18 | ↗ |
| 28 | Viking Global Opportunities GP LLC | 411.7K | 0.40% | — | 411.7K | — | 411.7K | OO | Delaware | 2022-01-18 | ↗ |
| 29 | Viking Global Opportunities Liquid Portfolio Sub-Master LP | 411.7K | 0.40% | — | 411.7K | — | 411.7K | PN | Delaware | 2022-01-18 | ↗ |
| 30 | Viking Global Opportunities Parent GP LLC | 411.7K | 0.40% | — | 411.7K | — | 411.7K | CO | Delaware | 2022-01-18 | ↗ |
| 31 | Viking Global Opportunities Portfolio GP LLC | 411.7K | 0.40% | — | 411.7K | — | 411.7K | OO | Delaware | 2022-01-18 | ↗ |
| 32 | Viking Global Equities II LP | 68.6K | 0.10% | — | 68.6K | — | 68.6K | PN | Delaware | 2022-01-18 | ↗ |
| 33 | 95-1411037 | 13.00 | 7.70% | 7.88M | — | 7.88M | — | IA | Delaware | 2023-02-13 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
137
-384 vs prev Q
New positions
20
Closed positions
382
Increased
74
Reduced
36
Put/Call ratio
0.00
Calls held
—
Puts held
100.0K
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 335.9K +335.9K (+100.0%) | 34.30B +34.3B (+100.0%) | 0.27% +0.269 pp | 0.49% +0.494 pp | USD102.14 +0.0% | 1 qtrs NEW |
| 2 | MACQUARIE MANAGEMENT HOLDINGS, INC. | 212.9K +212.9K (+100.0%) | 21.75B +21.8B (+100.0%) | 0.17% +0.171 pp | 0.03% +0.033 pp | USD102.14 +0.0% | 1 qtrs NEW |
| 3 | VANGUARD GROUP INC | 12.16M +251.9K (+2.1%) | 1.24B +498.0M (+66.9%) | 9.74% +0.149 pp | 0.02% +0.007 pp | USD73.99 +38.0% | 29 qtrs — |
| 4 | BLACKROCK, INC. | 11.32M -111.6K (-1.0%) | 1.16B +441.9M (+61.9%) | 9.07% -0.141 pp | 0.02% +0.007 pp | USD24.66 +314.2% | 6 qtrs — |
| 5 | PRICE T ROWE ASSOCIATES INC /MD/ | 5.64M +1.4M (+33.5%) | 575.67M +311.9M (+118.2%) | 4.52% +1.114 pp | 0.06% +0.034 pp | USD68.33 +49.5% | 29 qtrs — |
| 6 | INVESCO LTD. | 5.32M +386.4K (+7.8%) | 542.97M +235.0M (+76.3%) | 4.26% +0.288 pp | 0.08% +0.035 pp | USD49.42 +106.7% | 28 qtrs — |
| 7 | BAILLIE GIFFORD & CO | 4.89M -237.7K (-4.6%) | 499.47M +179.1M (+55.9%) | 3.92% -0.213 pp | 0.42% +0.178 pp | USD29.19 +249.9% | 9 qtrs — |
| 8 | CAPITAL INTERNATIONAL INVESTORS | 3.53M -1.2M (-24.8%) | 360.42M +67.4M (+23.0%) | 2.83% -0.951 pp | 0.06% +0.009 pp | USD55.87 +82.8% | 21 qtrs — |
| 9 | FRANKLIN RESOURCES INC | 3.36M +435.2K (+14.9%) | 343.35M +160.5M (+87.8%) | 2.69% +0.336 pp | 0.08% +0.039 pp | USD64.04 +59.5% | 29 qtrs — |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 3.21M +277.0K (+9.4%) | 328.30M +144.8M (+78.9%) | 2.57% +0.209 pp | 0.02% +0.009 pp | USD61.75 +65.4% | 29 qtrs — |
| 11 | DEEP TRACK CAPITAL, LP | 2.80M -1.4M (-32.6%) | 285.99M +26.4M (+10.2%) | 2.24% -1.104 pp | 5.10% -2.144 pp | USD27.83 +267.0% | 11 qtrs — |
| 12 | STATE STREET CORP | 2.80M +8.0K (+0.3%) | 285.56M +111.4M (+63.9%) | 2.24% -0.006 pp | 0.01% +0.004 pp | USD59.77 +70.9% | 29 qtrs — |
| 13 | GOLDMAN SACHS GROUP INC | 2.63M +1.1M (+74.5%) | 268.39M +174.3M (+185.2%) | 2.11% +0.892 pp | 0.03% +0.021 pp | USD75.51 +35.3% | 29 qtrs — |
| 14 | EVENTIDE ASSET MANAGEMENT, LLC | 2.51M -810.2K (-24.4%) | 256.45M +48.9M (+23.6%) | 2.01% -0.664 pp | 4.01% +0.594 pp | USD49.33 +107.1% | 18 qtrs — |
| 15 | FULLER & THALER ASSET MANAGEMENT, INC. | 2.44M +72.2K (+3.0%) | 249.40M +101.3M (+68.5%) | 1.96% +0.047 pp | 0.84% +0.339 pp | USD34.65 +194.8% | 7 qtrs — |
| 16 | FMR LLC | 2.40M +1.6M (+190.7%) | 244.77M +193.3M (+375.3%) | 1.92% +1.256 pp | 0.01% +0.010 pp | USD90.54 +12.8% | 29 qtrs — |
| 17 | TWO SIGMA ADVISERS, LP | 2.38M +269.5K (+12.8%) | 243.33M +111.3M (+84.3%) | 1.91% +0.207 pp | 0.47% +0.209 pp | USD38.04 +168.5% | 15 qtrs — |
| 18 | TWO SIGMA INVESTMENTS, LP | 2.17M +368.6K (+20.4%) | 221.84M +109.2M (+96.9%) | 1.74% +0.287 pp | 0.31% +0.145 pp | USD40.58 +151.7% | 15 qtrs — |
| 19 | DRIEHAUS CAPITAL MANAGEMENT LLC | 2.14M -9.1K (-0.4%) | 218.91M +84.4M (+62.8%) | 1.72% -0.017 pp | 1.49% +0.524 pp | USD44.67 +128.7% | 4 qtrs — |
| 20 | FEDERATED HERMES, INC. | 2.03M +255.2K (+14.4%) | 207.50M +96.5M (+87.0%) | 1.63% +0.197 pp | 0.35% +0.151 pp | USD51.49 +98.4% | 23 qtrs — |
| 21 | LORD, ABBETT & CO. LLC | 1.99M +465.3K (+30.5%) | 203.16M +108.0M (+113.4%) | 1.59% +0.366 pp | 0.62% +0.340 pp | USD62.89 +62.4% | 6 qtrs — |
| 22 | UBS ASSET MANAGEMENT AMERICAS INC | 1.92M -346.3K (-15.3%) | 195.66M +54.3M (+38.4%) | 1.53% -0.288 pp | 0.04% +0.011 pp | USD32.70 +212.4% | 27 qtrs — |
| 23 | ALLIANCEBERNSTEIN L.P. | 1.90M +1.8M (+1,262.7%) | 194.20M +185.5M (+2,127.7%) | 1.52% +1.411 pp | 0.06% +0.059 pp | USD97.26 +5.0% | 29 qtrs — |
| 24 | UBS GROUP AG | 1.71M +253.1K (+17.4%) | 174.68M +83.6M (+91.9%) | 1.37% +0.196 pp | 0.03% +0.014 pp | USD47.52 +114.9% | 29 qtrs — |
| 25 | POINT72 ASSET MANAGEMENT, L.P. | 1.50M +1.4M (+1,363.8%) | 153.13M +146.7M (+2,293.0%) | 1.20% +1.119 pp | 0.17% +0.161 pp | USD98.23 +4.0% | 11 qtrs — |
| 26 | RTW INVESTMENTS, LP | 1.48M +— (+0.0%) | 151.27M +58.7M (+63.5%) | 1.19% -0.007 pp | 1.52% +0.375 pp | USD56.44 +81.0% | 3 qtrs — |
| 27 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.46M +41.8K (+3.0%) | 148.89M +60.4M (+68.3%) | 1.17% +0.027 pp | 0.02% +0.009 pp | USD60.47 +68.9% | 29 qtrs — |
| 28 | BANK OF NEW YORK MELLON CORP | 1.37M +413.1K (+43.3%) | 139.54M +80.0M (+134.3%) | 1.09% +0.327 pp | 0.02% +0.013 pp | USD61.87 +65.1% | 29 qtrs — |
| 29 | ALYESKA INVESTMENT GROUP, L.P. | 1.34M -487.7K (-26.6%) | 137.24M +22.8M (+19.9%) | 1.08% -0.399 pp | 0.39% +0.042 pp | USD62.48 +63.5% | 2 qtrs — |
| 30 | NORGES BANK | 1.26M +1.3M (+100.0%) | 128.50M +128.5M (+100.0%) | 1.01% +1.008 pp | 0.01% +0.014 pp | USD102.14 +0.0% | 1 qtrs NEW |
| 31 | JENNISON ASSOCIATES LLC | 1.17M -301.0K (-20.5%) | 119.54M +27.6M (+30.0%) | 0.94% -0.248 pp | 0.07% +0.018 pp | USD57.40 +77.9% | 3 qtrs — |
| 32 | MORGAN STANLEY | 1.15M +171.8K (+17.5%) | 117.90M +56.5M (+92.1%) | 0.92% +0.133 pp | 0.01% +0.003 pp | USD58.00 +76.1% | 29 qtrs — |
| 33 | NORTHERN TRUST CORP | 1.10M -52.0K (-4.5%) | 112.64M +40.5M (+56.1%) | 0.88% -0.047 pp | 0.01% +0.005 pp | USD47.58 +114.7% | 29 qtrs — |
| 34 | ERSTE ASSET MANAGEMENT GMBH | 1.05M +340.7K (+48.3%) | 106.78M +63.1M (+144.3%) | 0.84% +0.270 pp | 0.90% +0.475 pp | USD60.28 +69.4% | 25 qtrs — |
| 35 | TEMASEK HOLDINGS (PRIVATE) LTD | 1.04M +— (+0.0%) | 106.64M +41.4M (+63.5%) | 0.84% -0.005 pp | 0.34% +0.113 pp | USD29.13 +250.6% | 29 qtrs — |
| 36 | BANK OF AMERICA CORP /DE/ | 1.02M +143.8K (+16.5%) | 103.94M +49.3M (+90.4%) | 0.82% +0.111 pp | 0.01% +0.004 pp | USD57.01 +79.2% | 29 qtrs — |
| 37 | HOOD RIVER CAPITAL MANAGEMENT LLC | 978.5K +721.6K (+280.9%) | 99.95M +83.9M (+522.7%) | 0.78% +0.577 pp | 1.10% +0.906 pp | USD83.68 +22.1% | 7 qtrs — |
| 38 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 956.2K +143.8K (+17.7%) | 97.67M +46.9M (+92.4%) | 0.77% +0.112 pp | 0.01% +0.006 pp | USD51.59 +98.0% | 28 qtrs — |
| 39 | CADIAN CAPITAL MANAGEMENT, LP | 922.6K -1.2M (-56.9%) | 94.24M -39.5M (-29.6%) | 0.74% -0.986 pp | 6.81% -1.144 pp | USD22.10 +362.2% | 9 qtrs — |
| 40 | EMERALD ADVISERS, LLC | 861.8K -11.4K (-1.3%) | 88.03M +33.5M (+61.3%) | 0.69% -0.013 pp | 2.71% +0.963 pp | USD48.37 +111.2% | 4 qtrs — |
| 41 | SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 852.0K +742.0K (+674.5%) | 87.02M +80.1M (+1,166.1%) | 0.68% +0.594 pp | 1.81% +1.667 pp | USD97.02 +5.3% | 2 qtrs — |
| 42 | AMERIPRISE FINANCIAL INC | 762.6K +455.1K (+148.0%) | 77.89M +58.7M (+305.4%) | 0.61% +0.363 pp | 0.02% +0.013 pp | USD79.10 +29.1% | 11 qtrs — |
| 43 | ARK INVESTMENT MANAGEMENT LLC | 691.6K -103.6K (-13.0%) | 70.64M +21.0M (+42.2%) | 0.55% -0.087 pp | 0.47% +0.173 pp | USD40.84 +150.1% | 14 qtrs — |
| 44 | SUMITOMO MITSUI TRUST HOLDINGS, INC. | 640.5K -113.6K (-15.1%) | 65.42M +18.3M (+38.8%) | 0.51% -0.094 pp | 0.04% +0.011 pp | USD33.82 +202.0% | 14 qtrs — |
| 45 | NIKKO ASSET MANAGEMENT AMERICAS, INC. | 640.3K -113.6K (-15.1%) | 65.38M +18.3M (+38.7%) | 0.51% -0.094 pp | 0.76% +0.299 pp | USD34.14 +199.2% | 14 qtrs — |
| 46 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 635.9K +1.5K (+0.2%) | 64.81M +25.2M (+63.5%) | 0.51% -0.002 pp | 0.05% +0.021 pp | USD54.08 +88.9% | 25 qtrs — |
| 47 | BNP PARIBAS ARBITRAGE, SNC | 624.8K +567.0K (+981.5%) | 63.81M +60.2M (+1,668.0%) | 0.50% +0.454 pp | 0.03% +0.027 pp | USD95.49 +7.0% | 27 qtrs — |
| 48 | D. E. SHAW & CO., INC. | 623.1K +589.7K (+1,768.4%) | 63.64M +61.6M (+2,954.4%) | 0.50% +0.472 pp | 0.03% +0.034 pp | USD100.02 +2.1% | 2 qtrs — |
| 49 | ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 618.6K -12.3K (-1.9%) | 62.94M +23.4M (+59.2%) | 0.50% -0.013 pp | 0.10% +0.039 pp | USD62.48 +63.5% | 2 qtrs — |
| 50 | RENAISSANCE TECHNOLOGIES LLC | 602.3K +70.5K (+13.2%) | 61.52M +28.3M (+85.1%) | 0.48% +0.054 pp | 0.10% +0.052 pp | USD38.00 +168.8% | 6 qtrs — |
| 51 | FRED ALGER MANAGEMENT, LLC | 589.7K -48.8K (-7.6%) | 60.23M +20.3M (+51.0%) | 0.47% -0.042 pp | 0.24% +0.081 pp | USD47.40 +115.5% | 29 qtrs — |
| 52 | MILLENNIUM MANAGEMENT LLC | 583.8K -294.8K (-33.6%) | 59.63M +4.7M (+8.6%) | 0.47% -0.240 pp | 0.03% +0.002 pp | USD42.64 +139.5% | 13 qtrs — |
| 53 | CITADEL ADVISORS LLC | 564.3K +259.8K (+85.3%) | 57.64M +38.6M (+203.0%) | 0.45% +0.207 pp | 0.01% +0.006 pp | USD66.90 +52.7% | 28 qtrs — |
| 54 | WESTFIELD CAPITAL MANAGEMENT CO LP | 539.2K +539.2K (+100.0%) | 55.07M +55.1M (+100.0%) | 0.43% +0.432 pp | 0.23% +0.229 pp | USD102.14 +0.0% | 1 qtrs NEW |
| 55 | EMERALD MUTUAL FUND ADVISERS TRUST | 523.9K -32.1K (-5.8%) | 53.51M +18.8M (+54.0%) | 0.42% -0.028 pp | 2.61% +0.813 pp | USD49.12 +107.9% | 4 qtrs — |
| 56 | JANE STREET GROUP, LLC | 513.6K +436.6K (+567.2%) | 52.46M +47.7M (+990.7%) | 0.41% +0.350 pp | 0.01% +0.007 pp | USD96.20 +6.2% | 27 qtrs — |
| 57 | BALYASNY ASSET MANAGEMENT L.P. | 505.6K -27.8K (-5.2%) | 51.64M +18.3M (+55.0%) | 0.41% -0.025 pp | 0.07% +0.023 pp | USD22.94 +345.2% | 23 qtrs — |
| 58 | ARISTOTLE ATLANTIC PARTNERS, LLC | 494.4K -429.3K (-46.5%) | 50.50M -7.2M (-12.5%) | 0.40% -0.348 pp | 2.31% +0.636 pp | USD43.52 +134.7% | 28 qtrs — |
| 59 | NUVEEN, LLC | 473.5K +18.5K (+4.1%) | 48.36M +19.9M (+70.1%) | 0.38% +0.013 pp | 0.01% +0.005 pp | USD52.69 +93.9% | 4 qtrs — |
| 60 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 464.9K +312.8K (+205.6%) | 47.49M +38.0M (+399.6%) | 0.37% +0.250 pp | 0.07% +0.057 pp | USD81.13 +25.9% | 8 qtrs — |
| 61 | JUPITER ASSET MANAGEMENT LTD | 421.3K +213.5K (+102.7%) | 43.03M +30.1M (+231.4%) | 0.34% +0.170 pp | 0.34% +0.233 pp | USD82.58 +23.7% | 2 qtrs — |
| 62 | WELLINGTON MANAGEMENT GROUP LLP | 406.5K -2.8M (-87.5%) | 41.52M -161.5M (-79.5%) | 0.33% -2.292 pp | 0.01% -0.028 pp | USD40.17 +154.3% | 11 qtrs — |
| 63 | CASDIN CAPITAL, LLC | 380.0K +280.0K (+280.0%) | 38.81M +32.6M (+521.2%) | 0.30% +0.224 pp | 2.41% +1.890 pp | USD81.70 +25.0% | 7 qtrs — |
| 64 | VICTORY CAPITAL MANAGEMENT INC | 377.0K -97.0K (-20.5%) | 38.51M +8.9M (+30.0%) | 0.30% -0.080 pp | 0.02% +0.004 pp | USD49.62 +105.8% | 29 qtrs — |
| 65 | BLUE WATER LIFE SCIENCE ADVISORS, LP | 355.0K -50.6K (-12.5%) | 36.26M +10.9M (+43.1%) | 0.28% -0.042 pp | 22.76% -0.363 pp | USD53.65 +90.4% | 21 qtrs — |
| 66 | DEUTSCHE BANK AG\ | 336.4K +576.0 (+0.2%) | 34.36M +13.4M (+63.8%) | 0.27% -0.001 pp | 0.01% +0.004 pp | USD29.19 +249.9% | 29 qtrs — |
| 67 | BARCLAYS PLC | 336.3K -550.8K (-62.1%) | 34.35M +14.0M (+68.8%) | 0.27% -0.445 pp | 0.01% +0.003 pp | USD52.14 +95.9% | 29 qtrs — |
| 68 | VOYA INVESTMENT MANAGEMENT LLC | 330.4K -26.0K (-7.3%) | 33.75M +11.5M (+51.6%) | 0.26% -0.022 pp | 0.03% +0.011 pp | USD41.37 +146.9% | 29 qtrs — |
| 69 | RAYMOND JAMES FINANCIAL INC | 328.6K -1.3K (-0.4%) | 33.24M +12.6M (+61.3%) | 0.26% -0.003 pp | 0.01% +0.004 pp | USD50.98 +100.4% | 5 qtrs — |
| 70 | DIMENSIONAL FUND ADVISORS LP | 306.6K +241.5K (+371.5%) | 31.30M +27.2M (+670.6%) | 0.25% +0.193 pp | 0.01% +0.006 pp | USD91.81 +11.3% | 4 qtrs — |
| 71 | MAN GROUP PLC | 295.8K -455.7K (-60.6%) | 30.21M -16.7M (-35.7%) | 0.24% -0.369 pp | 0.05% -0.030 pp | USD49.65 +105.7% | 12 qtrs — |
| 72 | FIRST LIGHT ASSET MANAGEMENT, LLC | 294.8K +14.8K (+5.3%) | 30.11M +12.6M (+72.1%) | 0.24% +0.011 pp | 2.30% +0.653 pp | USD48.32 +111.4% | 13 qtrs — |
| 73 | ARTISAN PARTNERS LIMITED PARTNERSHIP | 290.4K +290.4K (+100.0%) | 29.66M +29.7M (+100.0%) | 0.23% +0.233 pp | 0.04% +0.044 pp | USD102.14 +0.0% | 1 qtrs NEW |
| 74 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 287.5K -14.0K (-4.6%) | 29.21M +10.4M (+55.1%) | 0.23% -0.013 pp | 0.05% +0.016 pp | USD50.83 +100.9% | 4 qtrs — |
| 75 | EAGLE HEALTH INVESTMENTS LP | 284.1K +— (+0.0%) | 29.02M +11.3M (+63.5%) | 0.23% -0.001 pp | 6.38% +1.717 pp | USD54.69 +86.8% | 3 qtrs — |
| 76 | STYRAX CAPITAL, LP | 281.6K +281.6K (+100.0%) | 28.76M +28.8M (+100.0%) | 0.23% +0.226 pp | 2.20% +2.204 pp | USD102.14 +0.0% | 1 qtrs NEW |
| 77 | TREXQUANT INVESTMENT LP | 274.0K -110.7K (-28.8%) | 27.99M +4.0M (+16.4%) | 0.22% -0.090 pp | 0.25% +0.002 pp | USD41.30 +147.3% | 14 qtrs — |
| 78 | FIRST TURN MANAGEMENT, LLC | 271.7K +271.7K (+100.0%) | 27.75M +27.7M (+100.0%) | 0.22% +0.218 pp | 3.17% +3.171 pp | USD102.14 +0.0% | 4 qtrs — |
| 79 | JPMORGAN CHASE & CO | 271.0K -222.8K (-45.1%) | 27.68M -3.2M (-10.3%) | 0.22% -0.181 pp | 0.00% 0.000 pp | USD50.70 +101.5% | 29 qtrs — |
| 80 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 266.5K +121.1K (+83.3%) | 27.22M +18.1M (+199.7%) | 0.21% +0.096 pp | 0.07% +0.043 pp | USD80.51 +26.9% | 2 qtrs — |
| 81 | SEI INVESTMENTS CO | 261.9K +60.6K (+30.1%) | 26.75M +14.2M (+112.7%) | 0.21% +0.048 pp | 0.03% +0.013 pp | USD62.49 +63.5% | 7 qtrs — |
| 82 | WALLEYE CAPITAL LLC | 254.3K +185.5K (+269.7%) | 25.97M +21.7M (+504.3%) | 0.20% +0.148 pp | 0.08% +0.064 pp | USD91.21 +12.0% | 13 qtrs — |
| 83 | SEGALL BRYANT & HAMILL, LLC | 244.3K -60.9K (-20.0%) | 24.95M +5.9M (+30.9%) | 0.20% -0.050 pp | 0.34% +0.084 pp | USD55.87 +82.8% | 3 qtrs — |
| 84 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 237.5K -65.8K (-21.7%) | 24.26M +5.3M (+28.0%) | 0.19% -0.054 pp | 0.01% +0.002 pp | USD42.60 +139.8% | 4 qtrs — |
| 85 | SICART ASSOCIATES LLC | 228.2K -1.9K (-0.8%) | 23.31M +8.9M (+62.1%) | 0.18% -0.003 pp | 6.18% +2.290 pp | USD58.54 +74.5% | 19 qtrs — |
| 86 | SWISS NATIONAL BANK | 221.3K +5.2K (+2.4%) | 22.60M +9.1M (+67.4%) | 0.18% +0.003 pp | 0.01% +0.006 pp | USD76.06 +34.3% | 27 qtrs — |
| 87 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 215.1K +8.3K (+4.0%) | 21.97M +9.0M (+70.0%) | 0.17% +0.006 pp | 0.01% +0.005 pp | USD67.90 +50.4% | 27 qtrs — |
| 88 | WELLS FARGO & COMPANY/MN | 214.2K +100.2K (+87.9%) | 21.88M +14.8M (+207.2%) | 0.17% +0.080 pp | 0.00% +0.003 pp | USD73.38 +39.2% | 29 qtrs — |
| 89 | RUSSELL INVESTMENTS GROUP, LTD. | 211.4K +16.2K (+8.3%) | 21.59M +9.4M (+77.0%) | 0.17% +0.012 pp | 0.02% +0.010 pp | USD54.03 +89.0% | 24 qtrs — |
| 90 | RATHBONES GROUP PLC | 205.1K +5.0K (+2.5%) | 20.95M +8.4M (+67.6%) | 0.16% +0.003 pp | 0.08% +0.032 pp | USD71.94 +42.0% | 22 qtrs — |
| 91 | AXIOM INVESTORS LLC /DE | 203.6K +203.6K (+100.0%) | 20.80M +20.8M (+100.0%) | 0.16% +0.163 pp | 0.18% +0.183 pp | USD102.14 +0.0% | 1 qtrs NEW |
| 92 | CITIGROUP INC | 188.9K +169.7K (+883.1%) | 19.29M +18.1M (+1,507.1%) | 0.15% +0.136 pp | 0.01% +0.008 pp | USD94.26 +8.4% | 29 qtrs — |
| 93 | TD ASSET MANAGEMENT INC | 181.0K -7.8K (-4.1%) | 18.49M +6.7M (+56.8%) | 0.15% -0.007 pp | 0.01% +0.005 pp | USD51.30 +99.1% | 4 qtrs — |
| 94 | FIRST TRUST ADVISORS LP | 179.7K -6.5K (-3.5%) | 18.36M +6.7M (+57.8%) | 0.14% -0.006 pp | 0.01% +0.005 pp | USD37.40 +173.1% | 6 qtrs — |
| 95 | CAPTION MANAGEMENT, LLC | 175.0K -82.5K (-32.0%) | 17.87M +1.8M (+11.1%) | 0.14% -0.067 pp | 0.12% -0.003 pp | USD54.60 +87.1% | 4 qtrs — |
| 96 | MARSHALL WACE, LLP | 171.2K -70.1K (-29.1%) | 17.49M +2.4M (+16.0%) | 0.14% -0.057 pp | 0.02% +0.001 pp | USD62.48 +63.5% | 5 qtrs — |
| 97 | PARALLAX VOLATILITY ADVISERS, L.P. | 170.0K -1.2M (-87.9%) | 17.36M -70.1M (-80.1%) | 0.14% -0.992 pp | 0.03% -0.098 pp | USD28.65 +256.5% | 8 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.74
Neutral
Ratio by volume
0.65
Neutral
Buys
34
Sells
46
Shares acquired
153.8K
Shares disposed
235.6K
Cash buys
—
Cash sales
2.00
Net activity
-81,787
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-30 | Krognes Steve E. | Director | M-Exempt | A | Common Stock | 154 | 0.00 | — | 19,362 | D | ↗ |
| 2026-04-21 | MIGNONE ROBERTO | Director | M-Exempt | D | Restricted Stock Units | 264 | 0.00 | — | 7,920 | D | ↗ |
| 2026-04-17 | Hidalgo Medina Manuel | Director | M-Exempt | D | Restricted Stock Units | 232 | 0.00 | — | 6,265 | D | ↗ |
| 2026-04-16 | Tariq Musa | Director | S-Sale | D | Common Stock | 116 | 84.83 | 9.8K | 8,528 | D | ↗ |
| 2026-04-15 | Tariq Musa | Director | M-Exempt | D | Restricted Stock Units | 250 | 0.00 | — | 2,749 | D | ↗ |
| 2026-04-15 | Saia John G. | Officer | F-InKind | D | Common Stock | 3,970 | 84.86 | 336.9K | 65,950 | D | ↗ |
| 2026-04-06 | Monroe Terilyn J. | Officer | S-Sale | D | Common Stock | 3,832 | 92.68 | 355.1K | 20,990 | D | ↗ |
| 2026-04-01 | Talasaz AmirAli | Director / Officer | M-Exempt | A | Common Stock | 9,716 | 0.00 | — | 2,163,591 | I | ↗ |
| 2026-04-01 | Saia John G. | Officer | F-InKind | D | Common Stock | 6,013 | 91.15 | 548.1K | 62,351 | D | ↗ |
| 2026-04-01 | Monroe Terilyn J. | Officer | M-Exempt | A | Common Stock | 5,359 | 0.00 | — | 29,009 | D | ↗ |
| 2026-04-01 | Kalia Kumud | Officer | F-InKind | D | Common Stock | 5,092 | 91.15 | 464.1K | 49,249 | D | ↗ |
| 2026-04-01 | Freeman Chris | Officer | M-Exempt | D | Restricted Stock Units | 1,667 | 0.00 | — | 3,335 | D | ↗ |
| 2026-04-01 | Eltoukhy Helmy | Director / Officer | M-Exempt | A | Common Stock | 23,997 | 0.00 | — | 2,120,290 | I | ↗ |
| 2026-04-01 | EAGLE CRAIG | Officer | M-Exempt | A | Common Stock | 1,667 | 0.00 | — | 69,761 | D | ↗ |
| 2026-04-01 | Chudova Darya | Officer | M-Exempt | A | Common Stock | 3,324 | 0.00 | — | 70,682 | D | ↗ |
| 2026-04-01 | Bell Michael Brian | Officer | M-Exempt | A | Common Stock | 7,369 | 0.00 | — | 56,378 | D | ↗ |
| 2026-03-31 | Talasaz AmirAli | Director / Officer | M-Exempt | D | Restricted Stock Units | 2,817 | 0.00 | — | 8,451 | D | ↗ |
| 2026-03-31 | Krognes Steve E. | Director | M-Exempt | A | Common Stock | 155 | 0.00 | — | 19,208 | D | ↗ |
| 2026-03-31 | Eltoukhy Helmy | Director / Officer | F-InKind | D | Common Stock | 1,428 | 92.37 | 131.9K | 2,096,293 | I | ↗ |
| 2026-03-21 | MIGNONE ROBERTO | Director | M-Exempt | D | Restricted Stock Units | 264 | 0.00 | — | 8,184 | D | ↗ |
| 2026-03-18 | Tariq Musa | Director | S-Sale | D | Common Stock | 348 | 88.09 | 30.7K | 8,394 | D | ↗ |
| 2026-03-17 | Talasaz AmirAli | Director / Officer | A-Award | A | Restricted Stock Units | 101,409 | 0.00 | — | 101,409 | D | ↗ |
| 2026-03-17 | Hidalgo Medina Manuel | Director | M-Exempt | D | Restricted Stock Units | 232 | 0.00 | — | 6,497 | D | ↗ |
| 2026-03-17 | Eltoukhy Helmy | Director / Officer | A-Award | A | Restricted Stock Units | 11,268 | 0.00 | — | 11,268 | D | ↗ |
| 2026-03-16 | Bell Michael Brian | Officer | S-Sale | D | Common Stock | 3,000 | 87.04 | 261.1K | 43,601 | D | ↗ |
| 2026-03-15 | Tariq Musa | Director | M-Exempt | A | Common Stock | 249 | 0.00 | — | 8,742 | D | ↗ |
| 2026-03-15 | Saia John G. | Officer | M-Exempt | D | Restricted Stock Units | 1,019 | 0.00 | — | 1,020 | D | ↗ |
| 2026-03-15 | Kalia Kumud | Officer | M-Exempt | A | Common Stock | 637 | 0.00 | — | 51,136 | D | ↗ |
| 2026-03-15 | Freeman Chris | Officer | M-Exempt | A | Common Stock | 1,402 | 0.00 | — | 60,698 | D | ↗ |
| 2026-03-15 | EAGLE CRAIG | Officer | M-Exempt | D | Performance-Based Restricted Stock Units | 13,712 | 0.00 | — | 0 | D | ↗ |
| 2026-03-15 | Chudova Darya | Officer | M-Exempt | A | Common Stock | 10,714 | 0.00 | — | 70,111 | D | ↗ |
| 2026-03-15 | Bell Michael Brian | Officer | M-Exempt | D | Restricted Stock Units | 1,233 | 0.00 | — | 0 | D | ↗ |
| 2026-03-13 | Talasaz AmirAli | Director / Officer | M-Exempt | D | Performance-Based Restricted Stock Units | 26,961 | 0.00 | — | 0 | D | ↗ |
| 2026-03-13 | Eltoukhy Helmy | Director / Officer | M-Exempt | D | Performance-Based Restricted Stock Units | 26,961 | 0.00 | — | 0 | D | ↗ |
| 2026-03-11 | Saia John G. | Officer | A-Award | A | Restricted Stock Units | 20,448 | 0.00 | — | 20,448 | D | ↗ |
| 2026-03-11 | Monroe Terilyn J. | Officer | A-Award | A | Restricted Stock Units | 17,040 | 0.00 | — | 17,040 | D | ↗ |
| 2026-03-11 | Kalia Kumud | Officer | A-Award | A | Restricted Stock Units | 13,632 | 0.00 | — | 13,632 | D | ↗ |
| 2026-03-11 | Freeman Chris | Officer | A-Award | A | Restricted Stock Units | 18,744 | 0.00 | — | 18,744 | D | ↗ |
| 2026-03-11 | Chudova Darya | Officer | A-Award | A | Restricted Stock Units | 23,856 | 0.00 | — | 23,856 | D | ↗ |
| 2026-03-11 | Bell Michael Brian | Officer | A-Award | A | Restricted Stock Units | 26,582 | 0.00 | — | 26,582 | D | ↗ |
| 2026-03-06 | Hidalgo Medina Manuel | Director | S-Sale | D | Common Stock | 300 | 91.30 | 27.4K | 1,193 | D | ↗ |
| 2026-03-04 | Kalia Kumud | Officer | M-Exempt | D | Stock Option (Right to Buy) | 10,000 | 28.37 | 283.7K | 9,410 | D | ↗ |
| 2026-02-28 | Krognes Steve E. | Director | M-Exempt | A | Common Stock | 154 | 0.00 | — | 19,053 | D | ↗ |
| 2026-02-21 | MIGNONE ROBERTO | Director | M-Exempt | A | Common Stock | 264 | 0.00 | — | 4,223 | D | ↗ |
| 2026-02-17 | Hidalgo Medina Manuel | Director | M-Exempt | A | Common Stock | 232 | 0.00 | — | 1,493 | D | ↗ |
| 2026-02-15 | Tariq Musa | Director | M-Exempt | D | Restricted Stock Units | 250 | 0.00 | — | 3,248 | D | ↗ |
| 2026-01-31 | Krognes Steve E. | Director | M-Exempt | A | Common Stock | 154 | 0.00 | — | 18,899 | D | ↗ |
| 2026-01-21 | Monroe Terilyn J. | Officer | S-Sale | D | Common Stock | 1,703 | 112.34 | 191.3K | 27,858 | D | ↗ |
| 2026-01-21 | MIGNONE ROBERTO | Director | M-Exempt | D | Restricted Stock Units | 264 | 0.00 | — | 8,712 | D | ↗ |
| 2026-01-17 | Hidalgo Medina Manuel | Director | M-Exempt | D | Restricted Stock Units | 232 | 0.00 | — | 6,961 | D | ↗ |
| 2026-01-15 | Tariq Musa | Director | M-Exempt | A | Common Stock | 250 | 0.00 | — | 8,243 | D | ↗ |
| 2026-01-15 | Monroe Terilyn J. | Officer | M-Exempt | A | Common Stock | 17,379 | 0.00 | — | 38,369 | D | ↗ |
| 2026-01-07 | Monroe Terilyn J. | Officer | S-Sale | D | Common Stock | 88 | 113.44 | 10.0K | 20,990 | D | ↗ |
| 2026-01-01 | Talasaz AmirAli | Director / Officer | M-Exempt | A | Common Stock | 23,997 | 0.00 | — | 2,024,245 | D | ↗ |
| 2026-01-01 | Saia John G. | Officer | M-Exempt | D | Restricted Stock Units | 974 | 0.00 | — | 2,922 | D | ↗ |
| 2026-01-01 | Monroe Terilyn J. | Officer | M-Exempt | A | Common Stock | 2,659 | 0.00 | — | 38,545 | D | ↗ |
| 2026-01-01 | Kalia Kumud | Officer | F-InKind | D | Common Stock | 9,392 | 102.14 | 959.3K | 34,524 | D | ↗ |
| 2026-01-01 | Freeman Chris | Officer | M-Exempt | D | Performance-Based Restricted Stock Units | 15,428 | 0.00 | — | 0 | D | ↗ |
| 2026-01-01 | Eltoukhy Helmy | Director / Officer | J-Other | D | Common Stock | 13,209 | 0.00 | — | 0 | D | ↗ |
| 2026-01-01 | EAGLE CRAIG | Officer | M-Exempt | D | Restricted Stock Units | 2,659 | 0.00 | — | 18,615 | D | ↗ |
| 2026-01-01 | Chudova Darya | Officer | M-Exempt | D | Restricted Stock Units | 3,324 | 0.00 | — | 23,268 | D | ↗ |
| 2026-01-01 | Bell Michael Brian | Officer | M-Exempt | D | Restricted Stock Units | 3,324 | 0.00 | — | 23,268 | D | ↗ |
| 2025-12-31 | Talasaz AmirAli | Director / Officer | M-Exempt | D | Restricted Stock Units | 4,815 | 0.00 | — | 0 | D | ↗ |
| 2025-12-31 | Krognes Steve E. | Director | M-Exempt | D | Restricted Stock Units | 154 | 0.00 | — | 926 | D | ↗ |
| 2025-12-31 | Eltoukhy Helmy | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-12-31 | Chudova Darya | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-12-21 | MIGNONE ROBERTO | Director | M-Exempt | D | Restricted Stock Units | 264 | 0.00 | — | 8,976 | D | ↗ |
| 2025-12-17 | Tariq Musa | Director | S-Sale | D | Common Stock | 116 | 101.46 | 11.8K | 7,993 | D | ↗ |
| 2025-12-17 | Hidalgo Medina Manuel | Director | M-Exempt | A | Common Stock | 232 | 0.00 | — | 1,029 | D | ↗ |
| 2025-12-15 | Tariq Musa | Director | M-Exempt | A | Common Stock | 250 | 0.00 | — | 8,109 | D | ↗ |
| 2025-12-15 | Saia John G. | Officer | M-Exempt | D | Restricted Stock Units | 1,020 | 0.00 | — | 2,039 | D | ↗ |
| 2025-12-15 | Kalia Kumud | Officer | M-Exempt | A | Common Stock | 637 | 0.00 | — | 23,002 | D | ↗ |
| 2025-12-15 | Freeman Chris | Officer | M-Exempt | D | Restricted Stock Units | 1,402 | 0.00 | — | 2,804 | D | ↗ |
| 2025-12-15 | Eltoukhy Helmy | Director / Officer | S-Sale | D | Common Stock | 6,620 | 104.02 | 688.6K | 2,047,143 | D | ↗ |
| 2025-12-15 | EAGLE CRAIG | Officer | M-Exempt | D | Restricted Stock Units | 1,402 | 0.00 | — | 2,804 | D | ↗ |
| 2025-12-15 | Chudova Darya | Officer | S-Sale | D | Common Stock | 5,451 | 104.04 | 567.1K | 7,012 | D | ↗ |
| 2025-12-15 | Bell Michael Brian | Officer | M-Exempt | D | Restricted Stock Units | 1,233 | 0.00 | — | 1,233 | D | ↗ |
| 2025-12-08 | Talasaz AmirAli | Director / Officer | S-Sale | D | Common Stock | 4,240 | 106.00 | 449.4K | 168,223 | I | ↗ |
| 2025-12-08 | Kalia Kumud | Officer | S-Sale | D | Common Stock | 2,000 | 104.60 | 209.2K | 22,365 | D | ↗ |
| 2025-12-08 | Hidalgo Medina Manuel | Director | M-Exempt | A | Common Stock | 1,000 | 32.55 | 32.6K | 2,047 | D | ↗ |
| 2025-12-08 | Chudova Darya | Officer | S-Sale | D | Common Stock | 9,271 | 106.00 | 982.8K | 12,463 | D | ↗ |
| 2025-12-05 | Freeman Chris | Officer | S-Sale | D | Common Stock | 3,414 | 103.25 | 352.5K | 35,906 | D | ↗ |
| 2025-12-05 | CLARK IAN T | Director | M-Exempt | A | Common Stock | 8,803 | 38.01 | 334.6K | 27,759 | I | ↗ |
| 2025-12-05 | Bell Michael Brian | Officer | M-Exempt | D | Stock Option (Right to Buy) | 29,382 | 32.86 | 965.5K | 7,137 | D | ↗ |
| 2025-12-01 | Monroe Terilyn J. | Officer | M-Exempt | D | Stock Option (Right to Buy) | 15,000 | 28.61 | 429.2K | 32,627 | D | ↗ |
| 2025-11-30 | Krognes Steve E. | Director | M-Exempt | A | Common Stock | 155 | 0.00 | — | 18,591 | D | ↗ |
| 2025-11-21 | MIGNONE ROBERTO | Director | M-Exempt | D | Restricted Stock Units | 264 | 0.00 | — | 9,240 | D | ↗ |
| 2025-11-19 | Tariq Musa | Director | S-Sale | D | Common Stock | 116 | 96.25 | 11.2K | 7,859 | D | ↗ |
| 2025-11-17 | Hidalgo Medina Manuel | Director | M-Exempt | D | Restricted Stock Units | 232 | 0.00 | — | 7,425 | D | ↗ |
| 2025-11-15 | Tariq Musa | Director | M-Exempt | A | Common Stock | 250 | 0.00 | — | 7,975 | D | ↗ |
| 2025-11-07 | Saia John G. | Officer | S-Sale | D | Common Stock | 8,996 | 96.25 | 865.9K | 43,172 | D | ↗ |
| 2025-11-07 | Hidalgo Medina Manuel | Director | S-Sale | D | Common Stock | 1,000 | 95.17 | 95.2K | 1,315 | D | ↗ |
| 2025-10-31 | Krognes Steve E. | Director | M-Exempt | A | Common Stock | 154 | 0.00 | — | 18,436 | D | ↗ |
| 2025-10-21 | MIGNONE ROBERTO | Director | M-Exempt | D | Restricted Stock Units | 3,167 | 0.00 | — | 9,504 | D | ↗ |
| 2025-10-17 | Tariq Musa | Director | S-Sale | D | Common Stock | 116 | 66.95 | 7.8K | 7,725 | D | ↗ |
| 2025-10-17 | POTTER MYRTLE S | Director | S-Sale | D | Common Stock | 26 | 66.95 | 1.7K | 18,324 | D | ↗ |
| 2025-10-17 | Hidalgo Medina Manuel | Director | M-Exempt | D | Restricted Stock Units | 232 | 0.00 | — | 7,657 | D | ↗ |
| 2025-10-15 | Tariq Musa | Director | M-Exempt | D | Restricted Stock Units | 250 | 0.00 | — | 4,248 | D | ↗ |
| 2025-10-15 | POTTER MYRTLE S | Director | M-Exempt | D | Restricted Stock Units | 69 | 0.00 | — | 0 | D | ↗ |
| 2025-10-01 | Talasaz AmirAli | Director / Officer | F-InKind | D | Common Stock | 12,162 | 62.65 | 761.9K | 1,997,874 | D | ↗ |
| 2025-10-01 | Saia John G. | Officer | M-Exempt | A | Common Stock | 974 | 0.00 | — | 46,406 | D | ↗ |
| 2025-10-01 | Monroe Terilyn J. | Officer | M-Exempt | A | Common Stock | 10,477 | 0.00 | — | 31,397 | D | ↗ |
| 2025-10-01 | Kalia Kumud | Officer | F-InKind | D | Common Stock | 5,348 | 62.65 | 335.1K | 24,365 | D | ↗ |
| 2025-10-01 | Freeman Chris | Officer | M-Exempt | D | Restricted Stock Units | 1,668 | 0.00 | — | 6,669 | D | ↗ |
| 2025-10-01 | Eltoukhy Helmy | Director / Officer | M-Exempt | A | Common Stock | 23,997 | 0.00 | — | 2,149,870 | D | ↗ |
| 2025-10-01 | EAGLE CRAIG | Officer | M-Exempt | D | Restricted Stock Units | 1,668 | 0.00 | — | 6,669 | D | ↗ |
| 2025-10-01 | Chudova Darya | Officer | M-Exempt | A | Common Stock | 1,339 | 0.00 | — | 82,788 | D | ↗ |
| 2025-10-01 | Bell Michael Brian | Officer | M-Exempt | A | Common Stock | 13,097 | 0.00 | — | 59,822 | D | ↗ |
| 2025-09-30 | Talasaz AmirAli | Director / Officer | M-Exempt | D | Restricted Stock Units | 4,814 | 0.00 | — | 4,815 | D | ↗ |
| 2025-09-30 | Krognes Steve E. | Director | M-Exempt | D | Restricted Stock Units | 154 | 0.00 | — | 1,389 | D | ↗ |
| 2025-09-30 | Eltoukhy Helmy | Director / Officer | M-Exempt | D | Restricted Stock Units | 4,814 | 0.00 | — | 4,815 | D | ↗ |
| 2025-09-17 | Tariq Musa | Director | S-Sale | D | Common Stock | 116 | 55.63 | 6.5K | 7,591 | D | ↗ |
| 2025-09-17 | POTTER MYRTLE S | Director | S-Sale | D | Common Stock | 26 | 55.63 | 1.4K | 18,281 | D | ↗ |
| 2025-09-17 | Hidalgo Medina Manuel | Director | M-Exempt | D | Restricted Stock Units | 232 | 0.00 | — | 7,889 | D | ↗ |
| 2025-09-15 | Tariq Musa | Director | M-Exempt | D | Restricted Stock Units | 249 | 0.00 | — | 4,498 | D | ↗ |
| 2025-09-15 | Saia John G. | Officer | F-InKind | D | Common Stock | 535 | 54.79 | 29.3K | 45,432 | D | ↗ |
| 2025-09-15 | POTTER MYRTLE S | Director | M-Exempt | D | Restricted Stock Units | 68 | 0.00 | — | 69 | D | ↗ |
| 2025-09-15 | Kalia Kumud | Officer | F-InKind | D | Common Stock | 324 | 54.79 | 17.8K | 19,164 | D | ↗ |
| 2025-09-15 | Freeman Chris | Officer | M-Exempt | A | Common Stock | 1,402 | 0.00 | — | 50,223 | D | ↗ |
| 2025-09-15 | EAGLE CRAIG | Officer | F-InKind | D | Common Stock | 711 | 54.79 | 39.0K | 37,482 | D | ↗ |
| 2025-09-15 | Bell Michael Brian | Officer | M-Exempt | A | Common Stock | 2,039 | 0.00 | — | 46,300 | D | ↗ |
| 2025-09-12 | Hidalgo Medina Manuel | Director | S-Sale | D | Common Stock | 2,165 | 54.16 | 117.3K | 851 | D | ↗ |
| 2025-09-12 | Azar Alex M II | Director | A-Award | A | Stock Option (Right to Buy) | 10,532 | 54.90 | 578.2K | 10,532 | D | ↗ |
| 2025-09-09 | Eltoukhy Helmy | Director / Officer | S-Sale | D | Common Stock | 294,723 | 59.44 | 17.52M | 2,128,776 | D | ↗ |
| 2025-09-02 | Joyce Meghan V. | Director | S-Sale | D | Common Stock | 100 | 65.84 | 6.6K | 11,183 | D | ↗ |
| 2025-09-01 | Saia John G. | Officer | M-Exempt | A | Common Stock | 264 | 0.00 | — | 45,087 | D | ↗ |
| 2025-09-01 | Kalia Kumud | Officer | F-InKind | D | Common Stock | 361 | 67.42 | 24.3K | 18,850 | D | ↗ |
| 2025-09-01 | Chudova Darya | Officer | M-Exempt | D | Restricted Stock Units | 316 | 0.00 | — | 0 | D | ↗ |
| 2025-08-31 | Krognes Steve E. | Director | M-Exempt | A | Common Stock | 155 | 0.00 | — | 18,128 | D | ↗ |
| 2025-08-21 | Kalia Kumud | Officer | S-Sale | D | Common Stock | 2,000 | 61.76 | 123.5K | 18,500 | D | ↗ |
| 2025-08-19 | Tariq Musa | Director | S-Sale | D | Common Stock | 116 | 59.02 | 6.8K | 7,458 | D | ↗ |
| 2025-08-19 | POTTER MYRTLE S | Director | S-Sale | D | Common Stock | 26 | 59.02 | 1.5K | 18,239 | D | ↗ |
| 2025-08-17 | Hidalgo Medina Manuel | Director | M-Exempt | D | Restricted Stock Units | 232 | 0.00 | — | 8,121 | D | ↗ |
| 2025-08-15 | Tariq Musa | Director | M-Exempt | D | Restricted Stock Units | 250 | 0.00 | — | 4,747 | D | ↗ |
| 2025-08-15 | POTTER MYRTLE S | Director | M-Exempt | D | Restricted Stock Units | 69 | 0.00 | — | 137 | D | ↗ |
| 2025-08-04 | Joyce Meghan V. | Director | M-Exempt | A | Common Stock | 67 | 0.00 | — | 11,283 | D | ↗ |
| 2025-07-31 | Krognes Steve E. | Director | M-Exempt | A | Common Stock | 154 | 0.00 | — | 17,973 | D | ↗ |
| 2025-07-17 | Tariq Musa | Director | S-Sale | D | Common Stock | 116 | 48.20 | 5.6K | 7,324 | D | ↗ |
| 2025-07-17 | POTTER MYRTLE S | Director | S-Sale | D | Common Stock | 26 | 48.20 | 1.3K | 18,196 | D | ↗ |
| 2025-07-17 | Hidalgo Medina Manuel | Director | M-Exempt | D | Restricted Stock Units | 2,784 | 0.00 | — | 8,353 | D | ↗ |
| 2025-07-15 | Tariq Musa | Director | M-Exempt | D | Restricted Stock Units | 250 | 0.00 | — | 4,997 | D | ↗ |
| 2025-07-15 | POTTER MYRTLE S | Director | M-Exempt | A | Common Stock | 68 | 0.00 | — | 18,222 | D | ↗ |
| 2025-07-04 | Joyce Meghan V. | Director | M-Exempt | A | Common Stock | 66 | 0.00 | — | 11,216 | D | ↗ |
| 2025-07-01 | Talasaz AmirAli | Director / Officer | S-Sale | D | Common Stock | 72,068 | 50.67 | 3.65M | 1,999,762 | D | ↗ |
| 2025-07-01 | Saia John G. | Officer | M-Exempt | A | Common Stock | 974 | 0.00 | — | 44,542 | D | ↗ |
| 2025-07-01 | Kalia Kumud | Officer | F-InKind | D | Common Stock | 1,365 | 50.71 | 69.2K | 20,500 | D | ↗ |
| 2025-07-01 | Freeman Chris | Officer | M-Exempt | A | Common Stock | 1,667 | 0.00 | — | 50,353 | D | ↗ |
| 2025-07-01 | Eltoukhy Helmy | Director / Officer | F-InKind | D | Common Stock | 12,162 | 50.71 | 616.7K | 2,423,499 | D | ↗ |
| 2025-07-01 | EAGLE CRAIG | Officer | M-Exempt | D | Restricted Stock Units | 1,714 | 0.00 | — | 8,571 | D | ↗ |
| 2025-07-01 | Chudova Darya | Officer | M-Exempt | A | Common Stock | 1,667 | 0.00 | — | 82,819 | D | ↗ |
| 2025-07-01 | Bell Michael Brian | Officer | M-Exempt | D | Restricted Stock Units | 2,084 | 0.00 | — | 10,421 | D | ↗ |
| 2025-06-30 | Talasaz AmirAli | Director / Officer | M-Exempt | D | Restricted Stock Units | 4,815 | 0.00 | — | 9,629 | D | ↗ |
| 2025-06-30 | Krognes Steve E. | Director | M-Exempt | D | Restricted Stock Units | 154 | 0.00 | — | 1,852 | D | ↗ |
| 2025-06-30 | Eltoukhy Helmy | Director / Officer | F-InKind | D | Common Stock | 2,441 | 52.04 | 127.0K | 2,411,664 | D | ↗ |
| 2025-06-18 | Tariq Musa | Director | A-Award | A | Restricted Stock Units | 4,203 | 0.00 | — | 4,203 | D | ↗ |
| 2025-06-18 | POTTER MYRTLE S | Director | A-Award | A | Restricted Stock Units | 4,203 | 0.00 | — | 4,203 | D | ↗ |
| 2025-06-18 | MIGNONE ROBERTO | Director | A-Award | A | Restricted Stock Units | 4,203 | 0.00 | — | 4,203 | D | ↗ |
| 2025-06-18 | Krognes Steve E. | Director | A-Award | A | Stock Option (Right to Buy) | 6,833 | 50.57 | 345.5K | 6,833 | D | ↗ |
| 2025-06-18 | Joyce Meghan V. | Director | A-Award | A | Restricted Stock Units | 4,203 | 0.00 | — | 4,203 | D | ↗ |
| 2025-06-18 | Hidalgo Medina Manuel | Director | A-Award | A | Restricted Stock Units | 4,203 | 0.00 | — | 4,203 | D | ↗ |
| 2025-06-18 | Gadde Vijaya | Director | A-Award | A | Restricted Stock Units | 4,203 | 0.00 | — | 4,203 | D | ↗ |
| 2025-06-18 | CLARK IAN T | Director | A-Award | A | Restricted Stock Units | 5,092 | 0.00 | — | 5,092 | D | ↗ |
| 2025-06-17 | CLARK IAN T | Director | S-Sale | D | Common Stock | 6,672 | 48.38 | 322.8K | 9,851 | I | ↗ |
| 2025-06-16 | POTTER MYRTLE S | Director | S-Sale | D | Common Stock | 2,626 | 49.70 | 130.5K | 18,180 | D | ↗ |
| 2025-06-15 | Tariq Musa | Director | M-Exempt | A | Common Stock | 250 | 0.00 | — | 10,403 | D | ↗ |
| 2025-06-15 | Saia John G. | Officer | M-Exempt | A | Common Stock | 1,020 | 0.00 | — | 44,103 | D | ↗ |
| 2025-06-15 | POTTER MYRTLE S | Director | M-Exempt | A | Common Stock | 69 | 0.00 | — | 20,806 | D | ↗ |
| 2025-06-15 | Kalia Kumud | Officer | F-InKind | D | Common Stock | 228 | 49.29 | 11.2K | 19,174 | D | ↗ |
| 2025-06-15 | Freeman Chris | Officer | M-Exempt | D | Restricted Stock Units | 4,879 | 0.00 | — | 0 | D | ↗ |
| 2025-06-15 | EAGLE CRAIG | Officer | M-Exempt | D | Restricted Stock Units | 1,402 | 0.00 | — | 5,608 | D | ↗ |
| 2025-06-15 | Bell Michael Brian | Officer | M-Exempt | D | Restricted Stock Units | 2,039 | 0.00 | — | 8,156 | D | ↗ |
| 2025-06-13 | Joyce Meghan V. | Director | S-Sale | D | Common Stock | 3,337 | 47.22 | 157.6K | 11,150 | D | ↗ |
| 2025-06-12 | Tariq Musa | Director | M-Exempt | D | Restricted Stock Units | 6,674 | 0.00 | — | 0 | D | ↗ |
| 2025-06-12 | POTTER MYRTLE S | Director | M-Exempt | D | Restricted Stock Units | 6,674 | 0.00 | — | 0 | D | ↗ |
| 2025-06-12 | Krognes Steve E. | Director | M-Exempt | A | Common Stock | 6,674 | 0.00 | — | 17,665 | D | ↗ |
| 2025-06-12 | Joyce Meghan V. | Director | M-Exempt | D | Restricted Stock Units | 6,674 | 0.00 | — | 0 | D | ↗ |
| 2025-06-12 | Gadde Vijaya | Director | M-Exempt | D | Restricted Stock Units | 6,674 | 0.00 | — | 0 | D | ↗ |
| 2025-06-12 | CLARK IAN T | Director | M-Exempt | D | Restricted Stock Units | 8,088 | 0.00 | — | 0 | D | ↗ |
| 2025-06-09 | Talasaz AmirAli | Director / Officer | S-Sale | D | Common Stock | 77,853 | 50.09 | 3.90M | 2,069,456 | D | ↗ |
| 2025-06-06 | Talasaz AmirAli | Director / Officer | S-Sale | D | Common Stock | 39,751 | 50.07 | 1.99M | 2,147,309 | D | ↗ |
| 2025-06-05 | Talasaz AmirAli | Director / Officer | S-Sale | D | Common Stock | 1,680 | 50.00 | 84.0K | 2,187,060 | D | ↗ |
| 2025-06-04 | Joyce Meghan V. | Director | M-Exempt | D | Restricted Stock Units | 67 | 0.00 | — | 133 | D | ↗ |
| 2025-06-03 | Kalia Kumud | Officer | S-Sale | D | Common Stock | 4,000 | 46.39 | 185.6K | 18,765 | D | ↗ |
| 2025-06-02 | Joyce Meghan V. | Director | S-Sale | D | Common Stock | 100 | 41.66 | 4.2K | 7,746 | D | ↗ |
| 2025-06-01 | Saia John G. | Officer | M-Exempt | A | Common Stock | 263 | 0.00 | — | 43,221 | D | ↗ |
| 2025-06-01 | Kalia Kumud | Officer | M-Exempt | A | Common Stock | 710 | 0.00 | — | 23,019 | D | ↗ |
| 2025-06-01 | Chudova Darya | Officer | F-InKind | D | Common Stock | 161 | 40.62 | 6.5K | 79,812 | D | ↗ |
| 2025-05-31 | Krognes Steve E. | Director | M-Exempt | A | Common Stock | 154 | 0.00 | — | 10,991 | D | ↗ |
| 2025-05-19 | Tariq Musa | Director | S-Sale | D | Common Stock | 116 | 40.04 | 4.6K | 3,479 | D | ↗ |
| 2025-05-15 | Tariq Musa | Director | M-Exempt | A | Common Stock | 250 | 0.00 | — | 3,595 | D | ↗ |
| 2025-05-15 | POTTER MYRTLE S | Director | M-Exempt | A | Common Stock | 68 | 0.00 | — | 14,063 | D | ↗ |
| 2025-05-15 | EAGLE CRAIG | Officer | M-Exempt | A | Common Stock | 3,718 | 0.00 | — | 36,318 | D | ↗ |
| 2025-05-15 | Chudova Darya | Officer | F-InKind | D | Common Stock | 4,412 | 40.46 | 178.5K | 78,798 | D | ↗ |
| 2025-05-04 | Joyce Meghan V. | Director | M-Exempt | A | Common Stock | 66 | 0.00 | — | 7,846 | D | ↗ |
| 2025-05-02 | Talasaz AmirAli | Director / Officer | S-Sale | D | Common Stock | 13,932 | 50.47 | 703.2K | 2,188,740 | D | ↗ |
| 2025-05-01 | Talasaz AmirAli | Director / Officer | S-Sale | D | Common Stock | 44,691 | 49.53 | 2.21M | 2,208,219 | D | ↗ |
| 2025-04-30 | Krognes Steve E. | Director | M-Exempt | A | Common Stock | 155 | 0.00 | — | 10,837 | D | ↗ |
| 2025-04-17 | Tariq Musa | Director | S-Sale | D | Common Stock | 116 | 44.79 | 5.2K | 3,345 | D | ↗ |
| 2025-04-15 | Tariq Musa | Director | M-Exempt | A | Common Stock | 250 | 0.00 | — | 3,461 | D | ↗ |
| 2025-04-15 | Saia John G. | Officer | M-Exempt | A | Common Stock | 7,568 | 0.00 | — | 46,914 | D | ↗ |
Executive team
Top executives
EBIT / Employee
-165.1K
Shares Outstanding
131.17M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2023 | Ines Dahne-Steuber Former Chief Operating Officer | 307.1K | 50.0K | 2.61M | 2.55M | — | 317.4K | 5.84M | 88.44% | ↗ |
| 2 | 2023 | Darya Chudova Chief Technology Officer | 424.5K | — | 2.22M | 1.82M | 279.3K | 11.9K | 4.76M | 84.95% | ↗ |
| 3 | 2023 | Michael Bell Chief Financial Officer | 482.0K | — | 1.85M | 1.45M | 327.4K | 9.9K | 4.12M | 80.13% | ↗ |
| 4 | 2023 | Christopher Freeman Chief Commercial Officer | 490.4K | — | 1.62M | 1.08M | 327.4K | 8.4K | 3.52M | 76.55% | ↗ |
| 5 | 2023 | Craig Eagle Chief Medical Officer | 497.5K | — | 1.57M | 1.08M | 337.5K | 9.9K | 3.49M | 75.76% | ↗ |
| 6 | 2023 | AmirAli Talasaz Co-Chief Executive Officer | 1.00 | — | — | — | — | 26.4K | 26.4K | 0.00% | ↗ |
| 7 | 2023 | Helmy Eltoukhy Chairman and Co-Chief Executive Officer | 1.00 | — | — | — | — | 11.6K | 11.6K | 0.00% | ↗ |
| 8 | 2022 | John Saia Chief Legal Officer & Corporate Secretary | 466.2K | — | 2.39M | 3.01M | 148.2K | 12.9K | 6.02M | 89.58% | ↗ |
| 9 | 2022 | Christopher Freeman Chief Commercial Officer | 468.3K | — | 1.46M | 1.88M | 152.8K | 9.4K | 3.97M | 84.12% | ↗ |
| 10 | 2022 | Craig Eagle Chief Medical Officer | 485.2K | — | 1.29M | 1.67M | 157.3K | 6.6K | 3.62M | 82.05% | ↗ |
| 11 | 2022 | Michael Bell Chief Financial Officer | 466.1K | — | 604.2K | 742.5K | 155.0K | 10.0K | 1.98M | 68.09% | ↗ |
| 12 | 2022 | Helmy Eltoukhy Chairman and Co-Chief Executive Officer | 1.00 | — | — | — | — | 11.6K | 11.6K | 0.00% | ↗ |
| 13 | 2022 | AmirAli Talasaz Co-Chief Executive Officer | 1.00 | — | — | — | — | 11.2K | 11.2K | 0.00% | ↗ |
| 14 | 2021 | Michael Bell Chief Financial Officer | 439.6K | 500.0K | 2.94M | 2.32M | 250.2K | 11.0K | 6.46M | 81.41% | ↗ |
| 15 | 2021 | Craig Eagle Chief Medical Officer | 317.9K | 2.37M | 1.64M | 1.94M | 186.4K | 3.5K | 6.46M | 55.42% | ↗ |
| 16 | 2021 | Christopher Freeman Chief Commercial Officer | 249.2K | 300.0K | 2.16M | 2.54M | 183.9K | 7.1K | 5.44M | 86.38% | ↗ |
| 17 | 2021 | John Saia Chief Legal Officer & Corporate Secretary | 413.7K | 30.0K | 495.0K | 577.8K | 187.5K | 10.1K | 1.71M | 62.59% | ↗ |
| 18 | 2021 | Helmy Eltoukhy Chairman and Co-Chief Executive Officer | 1.00 | — | — | — | — | 13.7K | 13.7K | 0.00% | ↗ |
| 19 | 2021 | AmirAli Talasaz Co-Chief Executive Officer | 1.00 | — | — | — | — | 13.3K | 13.3K | 0.00% | ↗ |
| 20 | 2020 | AmirAli Talasaz Co-Chief Executive Officer | 209.9K | — | 113.60M | — | — | 79.8K | 113.89M | 99.75% | ↗ |
| 21 | 2020 | Helmy Eltoukhy Chairman and Co-Chief Executive Officer | 209.9K | — | 113.60M | — | — | 65.7K | 113.87M | 99.76% | ↗ |
| 22 | 2020 | John Saia Chief Legal Officer & Corporate Secretary | 304.3K | 30.0K | 1.36M | 1.23M | 196.8K | 9.4K | 3.14M | 82.77% | ↗ |
| 23 | 2019 | Richard Lanman Global Chief Medical Officer | 433.0K | 100.0K | 906.5K | 1.62M | — | 7.1K | 3.07M | 82.38% | ↗ |
| 24 | 2019 | Michael Wiley Chief Legal Officer | 392.3K | — | 544.0K | 971.6K | 306.3K | 1.9K | 2.22M | 68.39% | ↗ |
| 25 | 2019 | Derek Bertocci Chief Financial Officer | 378.3K | — | 544.0K | 971.6K | 226.5K | 9.2K | 2.13M | 71.17% | ↗ |
| 26 | 2019 | Helmy Eltoukhy Chief Executive Officer | 500.0K | — | — | — | 412.5K | 2.4K | 914.9K | 0.00% | ↗ |
| 27 | 2019 | AmirAli Talasaz President and Chief Operation Officer | 500.0K | — | — | — | 412.5K | 2.4K | 914.9K | 0.00% | ↗ |
| 28 | 2018 | Leena Das-Young Chief Lunar Officer | 199.0K | 165.7K | — | 1.06M | 42.3K | 250.0K | 1.72M | 61.76% | ↗ |
| 29 | 2018 | Richard Lanman Global Chief Medical Officer | 367.7K | 86.8K | — | 338.0K | 64.2K | 5.9K | 862.6K | 39.18% | ↗ |
| 30 | 2018 | Richard Lanman Chief Medical Officer | 367.7K | 86.8K | — | 338.0K | 64.2K | 5.9K | 862.6K | 39.18% | ↗ |
| 31 | 2018 | AmirAli Talasaz President and Chief Operating Officer | 480.0K | — | — | — | 336.0K | 2.4K | 818.4K | 0.00% | ↗ |
| 32 | 2018 | AmirAli Talasaz President and Chief Operation Officer | 480.0K | — | — | — | 336.0K | 2.4K | 818.4K | 0.00% | ↗ |
| 33 | 2018 | Helmy Eltoukhy Chief Executive Officer | 480.0K | — | — | — | 336.0K | 2.4K | 818.4K | 0.00% | ↗ |
| 34 | 2018 | Michael Wiley Chief Legal Officer | 384.0K | — | — | — | 269.0K | 1.5K | 654.5K | 0.00% | ↗ |
| 35 | 2017 | Helmy Eltoukhy Chief Executive Officer | 460.0K | — | — | 3.46M | 215.1K | 1.4K | 4.14M | 83.65% | ↗ |
| 36 | 2017 | AmirAli Talasaz President and Chief Operation Officer | 460.0K | — | — | 3.46M | 215.1K | 1.4K | 4.14M | 83.65% | ↗ |
| 37 | 2017 | AmirAli Talasaz President and Chief Operating Officer | 460.0K | — | — | 3.46M | 215.1K | 1.4K | 4.14M | 83.65% | ↗ |
| 38 | 2017 | Michael Wiley Chief Legal Officer | 384.0K | — | — | 470.7K | 179.5K | 1.5K | 1.04M | 45.45% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Michael Bell | Chief Financial Officer | 976.0K | male |
| John G. Saia | Chief Legal Officer & Corporate Secretary | 914.4K | male |
| Darya Chudova | Chief Technology Officer | 908.4K | female |
| Craig Eagle | Chief Medical Officer | 844.9K | — |
| Terilyn Juarez Monroe | Chief People Officer | 787.5K | female |
| AmirAli Talasaz | Co-CEO & Director | 13.5K | — |
| Helmy Eltoukhy | Co-Founder, Co-CEO & Chairman | 13.4K | — |
| Kumud Kalia | Chief Information Officer | — | male |
| Gulshan Shaver | Senior Vice President of Legal Affairs & Chief Compliance Officer | — | female |
| Noam Krantz | Senior Vice President of Corporate Development | — | male |
| Stephen Murphy | Senior Vice President of Screening Marketing | — | male |
| Andy Ament | Senior Vice President of Operations | — | male |
ESG Rating
ESG Score History MEDICAL - DIAGNOSTICS & RESEARCH
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
| Transaction Date | Disclosed | Senator | State | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2025-11-21 | 2025-12-01 | Sheldon Whitehouse | RI | Self | Purchase | $1,001 - $15,000 | ↗ |
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2022-02-28 | 2022-03-03 | Donald Sternoff Beyer | VA08 | Joint | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2022-01-13 | 2022-02-01 | Donald Sternoff Beyer | VA08 | Joint | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2021-12-22 | 2022-01-01 | Donald Sternoff Beyer | VA08 | Joint | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2020-11-02 | 2020-12-01 | Donald Sternoff Beyer | VA08 | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2020-10-22 | 2020-11-05 | Donald Sternoff Beyer | VA08 | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2020-10-05 | 2020-11-05 | Donald Sternoff Beyer | VA08 | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2020-07-14 | 2020-08-09 | Donald Sternoff Beyer | VA08 | Joint | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2020-05-01 | 2020-05-31 | Donald Sternoff Beyer | VA08 | Joint | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2020-04-27 | 2020-05-09 | Donald Sternoff Beyer | VA08 | Joint | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2020-02-14 | 2020-02-22 | Donald Sternoff Beyer | VA08 | Joint | Purchase | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GH
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
